[1]
J. S. Reddy and P. Shankaraiah, “Tangeretin suppresses HER2-driven breast cancer via PI3K/AKT/mTOR inhibition and caspase-dependent apoptosis”, Bangladesh J Pharmacol, vol. 21, no. 1, pp. 1–10, Mar. 2026.